Authors
Loading...
Retrospective analysis identifies KRAS mutation impact on treatment response in histiocytic neoplasms, suggesting variability in effectiveness of trametinib.
Shukla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: